Public invited to update on prostate cancer "active surveillance"

By Carol Hyman


Highlights of International Conference on Active Surveillance for Prostate Cancer


Public, patients, support group leaders, and family members.


Tuesday, February 27, 2007
4:00-5:30 PM


UCSF Mount Zion Medical Center
1600 Divisadero,
“B” Building, Herbst Hall


Peter Carroll, MD, professor and chair of the UCSF Department of Urology
Sara Knight, PhD, assistant professor of psychiatry and urology
Stan Rosenfeld, support group leader and patient advocate

Prostate cancer is the most common form of non-skin cancer in men in the United States and a leading cause of cancer mortality, accounting for more than 29,000 deaths in 2005. However, the natural history of this disease is remarkably variable and some men may be very good candidates for a program of active surveillance (“watchful waiting”) rather than immediate treatment. This presentation, especially for patients, will summarize information on which men with early stage prostate cancer might be the best candidates for this approach and outcomes to date.

UCSF is a leading university that advances health worldwide by conducting advanced biomedical research, educating graduate students in the life sciences and health professions, and providing complex patient care.